Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) saw a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 120,253 shares, an increase of 216.6% from the April 30th total of 37,978 shares. Based on an average daily volume of 38,663 shares, the days-to-cover ratio is currently 3.1 days.

Conduit Pharmaceuticals Stock Up 1.4%

Shares of CDTTW opened at $0.01 on Friday. Conduit Pharmaceuticals has a 12-month low of $0.01 and a 12-month high of $0.02. The firm’s 50 day moving average is $0.01 and its 200-day moving average is $0.01.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.